Sandbox g08
Jump to navigation
Jump to search
Adenosine Deaminase | [Chemical/Ingredient] |
Adenovirus Vaccines | [Chemical/Ingredient] |
Adrenocorticotropic Hormone | [Chemical/Ingredient] |
Allergens | [Chemical/Ingredient] |
Allylamine | [Chemical/Ingredient] |
alpha-Glucosidases | [Chemical/Ingredient] |
Amides | [Chemical/Ingredient] |
Amino Acids | [Chemical/Ingredient] |
Aminoglycosides | [Chemical/Ingredient] |
Aminosalicylic Acids | [Chemical/Ingredient] |
Amphenicols | [Chemical/Ingredient] |
Amphetamines | [Chemical/Ingredient] |
Analogs/Derivatives | [Chemical/Ingredient] |
Androstanes | [Chemical/Ingredient] |
Ant Venoms | [Chemical/Ingredient] |
Anthracyclines | [Chemical/Ingredient] |
Antibodies, Monoclonal | [Chemical/Ingredient] |
Antigens, Bacterial | [Chemical/Ingredient] |
Antigens, Dermatophagoides | [Chemical/Ingredient] |
Antigens, Fungal | [Chemical/Ingredient] |
Antitoxins | [Chemical/Ingredient] |
Antivenins | [Chemical/Ingredient] |
Aptamers, Nucleotide | [Chemical/Ingredient] |
Asparaginase | [Chemical/Ingredient] |
Azoles | [Chemical/Ingredient] |
Bacterial Proteins | [Chemical/Ingredient] |
Barbiturates | [Chemical/Ingredient] |
BCG Vaccine | [Chemical/Ingredient] |
Bee Venoms | [Chemical/Ingredient] |
Benzodiazepines | [Chemical/Ingredient] |
Benzothiazoles | [Chemical/Ingredient] |
Benzylamines | [Chemical/Ingredient] |
Biguanides | [Chemical/Ingredient] |
Bile Acids and Salts | [Chemical/Ingredient] |
Bismuth | [Chemical/Ingredient] |
Blood Coagulation Factors | [Chemical/Ingredient] |
Boron Compounds | [Chemical/Ingredient] |
Calcitonin | [Chemical/Ingredient] |
Calcium | [Chemical/Ingredient] |
Cannabinoids | [Chemical/Ingredient] |
Carbapenems | [Chemical/Ingredient] |
Carbon Radioisotopes | [Chemical/Ingredient] |
Cardiac Glycosides | [Chemical/Ingredient] |
Carnitine | [Chemical/Ingredient] |
Caseins | [Chemical/Ingredient] |
Catecholamines | [Chemical/Ingredient] |
Cations, Divalent | [Chemical/Ingredient] |
Cells, Allogeneic | [Chemical/Ingredient] |
Cells, Cultured, Allogeneic | [Chemical/Ingredient] |
Cells, Cultured, Autologous | [Chemical/Ingredient] |
Cells, Epidermal | [Chemical/Ingredient] |
Cephalosporins | [Chemical/Ingredient] |
Cholecalciferol | [Chemical/Ingredient] |
Cholecystokinin | [Chemical/Ingredient] |
Chondrocytes | [Chemical/Ingredient] |
Collagen | [Chemical/Ingredient] |
Collagenases | [Chemical/Ingredient] |
Copper | [Chemical/Ingredient] |
Dander | [Chemical/Ingredient] |
Deoxyribonuclease I | [Chemical/Ingredient] |
Deoxyuridine | [Chemical/Ingredient] |
Diarylquinolines | [Chemical/Ingredient] |
Dietary Proteins | [Chemical/Ingredient] |
Dihydropyridines | [Chemical/Ingredient] |
Diphosphonates | [Chemical/Ingredient] |
Diphtheria Toxin | [Chemical/Ingredient] |
Egg Proteins, Dietary | [Chemical/Ingredient] |
Enzyme Precursors | [Chemical/Ingredient] |
Ergocalciferols | [Chemical/Ingredient] |
Ergolines | [Chemical/Ingredient] |
Ergot Alkaloids | [Chemical/Ingredient] |
Ergotamines | [Chemical/Ingredient] |
Erythropoietin | [Chemical/Ingredient] |
Esters | [Chemical/Ingredient] |
Estradiol Congeners | [Chemical/Ingredient] |
Estradiol | [Chemical/Ingredient] |
Estrogens, Conjugated (USP) | [Chemical/Ingredient] |
Factor VIII | [Chemical/Ingredient] |
Fatty Acids, Omega-3 | [Chemical/Ingredient] |
Feathers | [Chemical/Ingredient] |
Fibroblast Growth Factor 7 | [Chemical/Ingredient] |
Fibroblasts | [Chemical/Ingredient] |
Fish Proteins, Dietary | [Chemical/Ingredient] |
Folic Acid | [Chemical/Ingredient] |
Food Additives | [Chemical/Ingredient] |
Fruit Proteins | [Chemical/Ingredient] |
Fungal Proteins | [Chemical/Ingredient] |
Fur | [Chemical/Ingredient] |
Glucagon-Like Peptide 1 | [Chemical/Ingredient] |
Glucosylceramidase | [Chemical/Ingredient] |
Glycerol | [Chemical/Ingredient] |
Glycopeptides | [Chemical/Ingredient] |
Glycosaminoglycans | [Chemical/Ingredient] |
Glycoside Hydrolases | [Chemical/Ingredient] |
Gonadotropins | [Chemical/Ingredient] |
Grain Proteins | [Chemical/Ingredient] |
Granulocyte Colony-Stimulating Factor | [Chemical/Ingredient] |
Granulocyte-Macrophage Colony-Stimulating Factor | [Chemical/Ingredient] |
Hematopoietic Stem Cells | [Chemical/Ingredient] |
Heparin | [Chemical/Ingredient] |
Heparin, Low-Molecular-Weight | [Chemical/Ingredient] |
House Dust | [Chemical/Ingredient] |
Immunoconjugates | [Chemical/Ingredient] |
Immunoglobulins | [Chemical/Ingredient] |
Insect Proteins | [Chemical/Ingredient] |
Insulin | [Chemical/Ingredient] |
Interferon Alfa-2b | [Chemical/Ingredient] |
Interferon-alpha | [Chemical/Ingredient] |
Interferon-beta | [Chemical/Ingredient] |
Interferon-gamma | [Chemical/Ingredient] |
Interleukin-2 | [Chemical/Ingredient] |
Iodine | [Chemical/Ingredient] |
Iron | [Chemical/Ingredient] |
Keratinocytes | [Chemical/Ingredient] |
Ketolides | [Chemical/Ingredient] |
Leptin | [Chemical/Ingredient] |
Lincosamides | [Chemical/Ingredient] |
Lipids | [Chemical/Ingredient] |
Lipoglycopeptides | [Chemical/Ingredient] |
Lipopeptides | [Chemical/Ingredient] |
Macrolides | [Chemical/Ingredient] |
Meat Proteins | [Chemical/Ingredient] |
Methylated Sulfonamides | [Chemical/Ingredient] |
Milk Proteins | [Chemical/Ingredient] |
Monobactams | [Chemical/Ingredient] |
Mumps Vaccine | [Chemical/Ingredient] |
N-substituted Glycines | [Chemical/Ingredient] |
Natriuretic Peptides | [Chemical/Ingredient] |
Nicotine | [Chemical/Ingredient] |
Nicotinic Acids | [Chemical/Ingredient] |
Nitrates | [Chemical/Ingredient] |
Nitrofurans | [Chemical/Ingredient] |
Nitrogen Mustard Compounds | [Chemical/Ingredient] |
Nitroimidazoles | [Chemical/Ingredient] |
Non-Nucleoside Analog | [Chemical/Ingredient] |
Nonsteroidal Anti-inflammatory Compounds | [Chemical/Ingredient] |
Nucleoside Analog | [Chemical/Ingredient] |
Nut Proteins | [Chemical/Ingredient] |
Oligonucleotides | [Chemical/Ingredient] |
Organometallic Compounds | [Chemical/Ingredient] |
Oxazolidinones | [Chemical/Ingredient] |
Oxytocin | [Chemical/Ingredient] |
Parathyroid Hormone | [Chemical/Ingredient] |
peginterferon alfa-2a | [Chemical/Ingredient] |
peginterferon alfa-2b | [Chemical/Ingredient] |
Penicillins | [Chemical/Ingredient] |
Peripheral Blood Mononuclear Cells | [Chemical/Ingredient] |
Phenothiazines | [Chemical/Ingredient] |
Plant Proteins | [Chemical/Ingredient] |
Platelet-Derived Growth Factor | [Chemical/Ingredient] |
Platinum-containing Compounds | [Chemical/Ingredient] |
pleuromutilin | [Chemical/Ingredient] |
Pollen | [Chemical/Ingredient] |
Polyenes | [Chemical/Ingredient] |
Polymyxins | [Chemical/Ingredient] |
Porphyrinogens | [Chemical/Ingredient] |
Potassium Compounds | [Chemical/Ingredient] |
Poultry Proteins | [Chemical/Ingredient] |
PPAR alpha | [Chemical/Ingredient] |
PPAR gamma | [Chemical/Ingredient] |
Progesterone Congeners | [Chemical/Ingredient] |
Progesterone | [Chemical/Ingredient] |
Prostaglandins E, Synthetic | [Chemical/Ingredient] |
Prostaglandins I | [Chemical/Ingredient] |
Prostaglandins | [Chemical/Ingredient] |
Protein C | [Chemical/Ingredient] |
Psoralens | [Chemical/Ingredient] |
Purines | [Chemical/Ingredient] |
Pyrethrins | [Chemical/Ingredient] |
Pyridones | [Chemical/Ingredient] |
Pyrophosphate Analog | [Chemical/Ingredient] |
Quaternary Ammonium Compounds | [Chemical/Ingredient] |
Quinolones | [Chemical/Ingredient] |
Radioactive Tracers | [Chemical/Ingredient] |
Recombinant Fusion Proteins | [Chemical/Ingredient] |
Recombinant Human Growth Hormones | [Chemical/Ingredient] |
Recombinant Proteins | [Chemical/Ingredient] |
Retinoids | [Chemical/Ingredient] |
Rifamycins | [Chemical/Ingredient] |
Rotavirus Vaccines | [Chemical/Ingredient] |
Salivary Proteins and Peptides | [Chemical/Ingredient] |
Seed Storage Proteins | [Chemical/Ingredient] |
Serum Albumin | [Chemical/Ingredient] |
Shellfish Proteins | [Chemical/Ingredient] |
Silk | [Chemical/Ingredient] |
Starch | [Chemical/Ingredient] |
Streptogramins | [Chemical/Ingredient] |
Sulfonamides | [Chemical/Ingredient] |
Sulfones | [Chemical/Ingredient] |
Sulfonylurea Compounds | [Chemical/Ingredient] |
Tetracyclines | [Chemical/Ingredient] |
Thiazides | [Chemical/Ingredient] |
Thiazolidinediones | [Chemical/Ingredient] |
Thrombopoietin | [Chemical/Ingredient] |
Thyrotropin | [Chemical/Ingredient] |
Thyroxine | [Chemical/Ingredient] |
Tissue Scaffolds | [Chemical/Ingredient] |
Transglutaminases | [Chemical/Ingredient] |
Triiodothyronine | [Chemical/Ingredient] |
Urate Oxidase | [Chemical/Ingredient] |
Urea | [Chemical/Ingredient] |
Vaccines, Attenuated | [Chemical/Ingredient] |
Vaccines, Inactivated | [Chemical/Ingredient] |
Vaccines, Live, Unattenuated | [Chemical/Ingredient] |
Vaccines, Typhoid | [Chemical/Ingredient] |
Vasopressins | [Chemical/Ingredient] |
Vegetable Proteins | [Chemical/Ingredient] |
Vi polysaccharide vaccine, typhoid | [Chemical/Ingredient] |
Vinca Alkaloids | [Chemical/Ingredient] |
Virus-specific Hyperimmune Globulins | [Chemical/Ingredient] |
Vitamin A | [Chemical/Ingredient] |
Vitamin B 12 | [Chemical/Ingredient] |
Vitamin B Complex Compounds | [Chemical/Ingredient] |
Vitamin D | [Chemical/Ingredient] |
Vitamin K | [Chemical/Ingredient] |
von Willebrand Factor | [Chemical/Ingredient] |
Wasp Venoms | [Chemical/Ingredient] |
Xanthines | [Chemical/Ingredient] |
5-alpha Reductase Inhibitor | [FDA Established Pharmacologic Classes] |
5-Lipoxygenase Inhibitor | [FDA Established Pharmacologic Classes] |
Acetylcholine Release Inhibitor | [FDA Established Pharmacologic Classes] |
Acetylcholine Releasing Agent | [FDA Established Pharmacologic Classes] |
Actinomycin | [FDA Established Pharmacologic Classes] |
Adenosine Receptor Agonist | [FDA Established Pharmacologic Classes] |
Adrenal Steroid Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
Adrenergic Receptor Agonist | [FDA Established Pharmacologic Classes] |
Adrenocorticotropic Hormone | [FDA Established Pharmacologic Classes] |
Aldehyde Dehydrogenase Inhibitor | [FDA Established Pharmacologic Classes] |
Aldosterone Antagonist | [FDA Established Pharmacologic Classes] |
Alkylating Drug | [FDA Established Pharmacologic Classes] |
Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy | [FDA Established Pharmacologic Classes] |
Allogeneic Cultured Cell Scaffold | [FDA Established Pharmacologic Classes] |
Allylamine Antifungal | [FDA Established Pharmacologic Classes] |
alpha-1 Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
alpha-Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
alpha-Adrenergic Blocker | [FDA Established Pharmacologic Classes] |
alpha-Glucosidase Inhibitor | [FDA Established Pharmacologic Classes] |
Aluminum Complex | [FDA Established Pharmacologic Classes] |
Amide Local Anesthetic | [FDA Established Pharmacologic Classes] |
Amino Acid Hypertonic Solution | [FDA Established Pharmacologic Classes] |
Amino Acid | [FDA Established Pharmacologic Classes] |
Aminoglycoside Antibacterial | [FDA Established Pharmacologic Classes] |
Aminoketone | [FDA Established Pharmacologic Classes] |
Aminosalicylate | [FDA Established Pharmacologic Classes] |
Amphenicol-class Antibacterial | [FDA Established Pharmacologic Classes] |
Amphetamine Anorectic | [FDA Established Pharmacologic Classes] |
Amylin Analog | [FDA Established Pharmacologic Classes] |
Androgen Receptor Inhibitor | [FDA Established Pharmacologic Classes] |
Androgen | [FDA Established Pharmacologic Classes] |
Angiotensin 2 Receptor Blocker | [FDA Established Pharmacologic Classes] |
Angiotensin Converting Enzyme Inhibitor | [FDA Established Pharmacologic Classes] |
Anthracycline Topoisomerase Inhibitor | [FDA Established Pharmacologic Classes] |
Anti-anginal | [FDA Established Pharmacologic Classes] |
Anti-coagulant | [FDA Established Pharmacologic Classes] |
Anti-epileptic Agent | [FDA Established Pharmacologic Classes] |
Anti-IgE | [FDA Established Pharmacologic Classes] |
Anti-inhibitor Coagulant Complex | [FDA Established Pharmacologic Classes] |
Antiarrhythmic | [FDA Established Pharmacologic Classes] |
Anticholinergic | [FDA Established Pharmacologic Classes] |
Antidiarrheal | [FDA Established Pharmacologic Classes] |
Antidote for Acetaminophen Overdose | [FDA Established Pharmacologic Classes] |
Antidote | [FDA Established Pharmacologic Classes] |
Antiemetic | [FDA Established Pharmacologic Classes] |
Antifibrinolytic Agent | [FDA Established Pharmacologic Classes] |
Antihelminthic | [FDA Established Pharmacologic Classes] |
Antihistamine | [FDA Established Pharmacologic Classes] |
Antihypoglycemic Agent | [FDA Established Pharmacologic Classes] |
Antileishmanial | [FDA Established Pharmacologic Classes] |
Antimalarial | [FDA Established Pharmacologic Classes] |
Antimetabolite Immunosuppressant | [FDA Established Pharmacologic Classes] |
Antimetabolite | [FDA Established Pharmacologic Classes] |
Antimycobacterial | [FDA Established Pharmacologic Classes] |
Antiparasitic | [FDA Established Pharmacologic Classes] |
Antiprotozoal | [FDA Established Pharmacologic Classes] |
Antirheumatic Agent | [FDA Established Pharmacologic Classes] |
Antiseptic | [FDA Established Pharmacologic Classes] |
Antivenin | [FDA Established Pharmacologic Classes] |
Aromatase Inhibitor | [FDA Established Pharmacologic Classes] |
Aromatic Amino Acid Decarboxylation Inhibitor | [FDA Established Pharmacologic Classes] |
Arteriolar Vasodilator | [FDA Established Pharmacologic Classes] |
Asparagine-specific Enzyme | [FDA Established Pharmacologic Classes] |
Atypical Antipsychotic | [FDA Established Pharmacologic Classes] |
Autologous Cellular Immunotherapy | [FDA Established Pharmacologic Classes] |
Autologous Cultured Cell | [FDA Established Pharmacologic Classes] |
Autonomic Ganglionic Blocker | [FDA Established Pharmacologic Classes] |
Azole Antifungal | [FDA Established Pharmacologic Classes] |
B Lymphocyte Stimulator-specific Inhibitor | [FDA Established Pharmacologic Classes] |
Barbiturate | [FDA Established Pharmacologic Classes] |
Benzodiazepine Antagonist | [FDA Established Pharmacologic Classes] |
Benzodiazepine | [FDA Established Pharmacologic Classes] |
Benzothiazole | [FDA Established Pharmacologic Classes] |
Benzylamine Antifungal | [FDA Established Pharmacologic Classes] |
beta Lactamase Inhibitor | [FDA Established Pharmacologic Classes] |
beta-Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
beta-Adrenergic Blocker | [FDA Established Pharmacologic Classes] |
beta2-Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
beta3-Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
Biguanide | [FDA Established Pharmacologic Classes] |
Bile Acid Sequestrant | [FDA Established Pharmacologic Classes] |
Bile Acid | [FDA Established Pharmacologic Classes] |
Bismuth | [FDA Established Pharmacologic Classes] |
Bisphosphonate | [FDA Established Pharmacologic Classes] |
Blood Coagulation Factor | [FDA Established Pharmacologic Classes] |
Blood Viscosity Reducer | [FDA Established Pharmacologic Classes] |
Bovine Intestinal Adenosine Deaminase | [FDA Established Pharmacologic Classes] |
Bradykinin B2 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Calcineurin Inhibitor Immunosuppressant | [FDA Established Pharmacologic Classes] |
Calcitonin | [FDA Established Pharmacologic Classes] |
Calcium Channel Blocker | [FDA Established Pharmacologic Classes] |
Calcium | [FDA Established Pharmacologic Classes] |
Calcium-sensing Receptor Agonist | [FDA Established Pharmacologic Classes] |
Calculi Dissolution Agent | [FDA Established Pharmacologic Classes] |
Cannabinoid | [FDA Established Pharmacologic Classes] |
Carbamoyl Phosphate Synthetase 1 Activator | [FDA Established Pharmacologic Classes] |
Carbonic Anhydrase Inhibitor | [FDA Established Pharmacologic Classes] |
Cardiac Glycoside | [FDA Established Pharmacologic Classes] |
Carnitine Analog | [FDA Established Pharmacologic Classes] |
Catechol-O-Methyltransferase Inhibitor | [FDA Established Pharmacologic Classes] |
Catecholamine Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
Catecholamine | [FDA Established Pharmacologic Classes] |
Catecholamine-depleting Sympatholytic | [FDA Established Pharmacologic Classes] |
CCR5 Co-receptor Antagonist | [FDA Established Pharmacologic Classes] |
CD20-directed Cytolytic Antibody | [FDA Established Pharmacologic Classes] |
CD20-directed Radiotherapeutic Antibody | [FDA Established Pharmacologic Classes] |
CD25-directed Cytotoxin | [FDA Established Pharmacologic Classes] |
CD3 Blocker Immunosuppressant | [FDA Established Pharmacologic Classes] |
CD30-directed Immunoconjugate | [FDA Established Pharmacologic Classes] |
CD52-directed Cytolytic Antibody | [FDA Established Pharmacologic Classes] |
Cell Death Inducer | [FDA Established Pharmacologic Classes] |
Central alpha-2 Adrenergic Agonist | [FDA Established Pharmacologic Classes] |
Central Nervous System Depressant | [FDA Established Pharmacologic Classes] |
Central Nervous System Stimulant | [FDA Established Pharmacologic Classes] |
Cephalosporin Antibacterial | [FDA Established Pharmacologic Classes] |
Chloride Channel Activator | [FDA Established Pharmacologic Classes] |
Cholecystokinin Analog | [FDA Established Pharmacologic Classes] |
Cholinergic Muscarinic Agonist | [FDA Established Pharmacologic Classes] |
Cholinergic Muscarinic Antagonist | [FDA Established Pharmacologic Classes] |
Cholinergic Nicotinic Agonist | [FDA Established Pharmacologic Classes] |
Cholinergic Receptor Agonist | [FDA Established Pharmacologic Classes] |
Cholinesterase Inhibitor | [FDA Established Pharmacologic Classes] |
Cholinesterase Reactivator | [FDA Established Pharmacologic Classes] |
Collagen-specific Enzyme | [FDA Established Pharmacologic Classes] |
Complement Inhibitor | [FDA Established Pharmacologic Classes] |
Contrast Agent for Ultrasound Imaging | [FDA Established Pharmacologic Classes] |
Copper Absorption Inhibitor | [FDA Established Pharmacologic Classes] |
Copper-containing Intrauterine Device | [FDA Established Pharmacologic Classes] |
Corticosteroid | [FDA Established Pharmacologic Classes] |
CTLA-4-directed Blocking Antibody | [FDA Established Pharmacologic Classes] |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator | [FDA Established Pharmacologic Classes] |
Cystine Depleting Agent | [FDA Established Pharmacologic Classes] |
Cytochrome P450 17A1 Inhibitor | [FDA Established Pharmacologic Classes] |
Cytochrome P450 2D6 Inhibitor | [FDA Established Pharmacologic Classes] |
Cytochrome P450 3A Inhibitor | [FDA Established Pharmacologic Classes] |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
Cytoprotective Agent | [FDA Established Pharmacologic Classes] |
Decarboxylase Inhibitor | [FDA Established Pharmacologic Classes] |
Demulcent | [FDA Established Pharmacologic Classes] |
Depigmenting Agent | [FDA Established Pharmacologic Classes] |
Depolarizing Neuromuscular Blocker | [FDA Established Pharmacologic Classes] |
Diagnostic Dye | [FDA Established Pharmacologic Classes] |
Diarylquinoline Antimycobacterial | [FDA Established Pharmacologic Classes] |
Dietary Cholesterol Absorption Inhibitor | [FDA Established Pharmacologic Classes] |
Dihydrofolate Reductase Inhibitor Antibacterial | [FDA Established Pharmacologic Classes] |
Dihydrofolate Reductase Inhibitor Antimalarial | [FDA Established Pharmacologic Classes] |
Dihydropyridine Calcium Channel Blocker | [FDA Established Pharmacologic Classes] |
Dipeptidyl Peptidase 4 Inhibitor | [FDA Established Pharmacologic Classes] |
Direct Thrombin Inhibitor | [FDA Established Pharmacologic Classes] |
Dopamine-2 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Dopaminergic Agonist | [FDA Established Pharmacologic Classes] |
Echinocandin Antifungal | [FDA Established Pharmacologic Classes] |
Endoglycosidase | [FDA Established Pharmacologic Classes] |
Endothelin Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Epidermal Growth Factor Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Ergot Derivative | [FDA Established Pharmacologic Classes] |
Ergot-derived Dopamine Receptor Agonist | [FDA Established Pharmacologic Classes] |
Ergotamine Derivative | [FDA Established Pharmacologic Classes] |
Erythropoiesis-stimulating Agent | [FDA Established Pharmacologic Classes] |
Ester Local Anesthetic | [FDA Established Pharmacologic Classes] |
Estrogen Agonist/Antagonist | [FDA Established Pharmacologic Classes] |
Estrogen Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Estrogen | [FDA Established Pharmacologic Classes] |
Factor VIII Activator | [FDA Established Pharmacologic Classes] |
Factor Xa Inhibitor | [FDA Established Pharmacologic Classes] |
Folate Analog Metabolic Inhibitor | [FDA Established Pharmacologic Classes] |
Folate Analog | [FDA Established Pharmacologic Classes] |
Gadolinium-based Contrast Agent | [FDA Established Pharmacologic Classes] |
gamma-Aminobutyric Acid A Receptor Agonist | [FDA Established Pharmacologic Classes] |
gamma-Aminobutyric Acid-ergic Agonist | [FDA Established Pharmacologic Classes] |
Gastrointestinal Motility Inhibitor | [FDA Established Pharmacologic Classes] |
General Anesthetic | [FDA Established Pharmacologic Classes] |
Glinide | [FDA Established Pharmacologic Classes] |
GLP-1 Receptor Agonist | [FDA Established Pharmacologic Classes] |
Glucosylceramide Synthase Inhibitor | [FDA Established Pharmacologic Classes] |
Glycopeptide Antibacterial | [FDA Established Pharmacologic Classes] |
Glycosaminoglycan | [FDA Established Pharmacologic Classes] |
Gonadotropin Releasing Hormone Antagonist | [FDA Established Pharmacologic Classes] |
Gonadotropin Releasing Hormone Receptor Agonist | [FDA Established Pharmacologic Classes] |
Gonadotropin | [FDA Established Pharmacologic Classes] |
Growth Hormone Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Growth Hormone Releasing Factor Analog | [FDA Established Pharmacologic Classes] |
Guanylate Cyclase-C Agonist | [FDA Established Pharmacologic Classes] |
Hedgehog Pathway Inhibitor | [FDA Established Pharmacologic Classes] |
Helicobacter pylori Diagnostic | [FDA Established Pharmacologic Classes] |
Hematopoietic Stem Cell Mobilizer | [FDA Established Pharmacologic Classes] |
Heparin Reversal Agent | [FDA Established Pharmacologic Classes] |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor | [FDA Established Pharmacologic Classes] |
Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
Hepatitis C Virus NS3/4A Protease Inhibitor | [FDA Established Pharmacologic Classes] |
Hepatitis C Virus NS5A Inhibitor | [FDA Established Pharmacologic Classes] |
HER2 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
Histamine-1 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Histamine-1 Receptor Inhibitor | [FDA Established Pharmacologic Classes] |
Histamine-2 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Histone Deacetylase Inhibitor | [FDA Established Pharmacologic Classes] |
HMG-CoA Reductase Inhibitor | [FDA Established Pharmacologic Classes] |
Human alpha-1 Proteinase Inhibitor | [FDA Established Pharmacologic Classes] |
Human Antihemophilic Factor | [FDA Established Pharmacologic Classes] |
Human Blood Coagulation Factor | [FDA Established Pharmacologic Classes] |
Human C1 Esterase Inhibitor | [FDA Established Pharmacologic Classes] |
Human Immunodeficiency Virus 1 Fusion Inhibitor | [FDA Established Pharmacologic Classes] |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor | [FDA Established Pharmacologic Classes] |
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor | [FDA Established Pharmacologic Classes] |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor | [FDA Established Pharmacologic Classes] |
Human Immunoglobulin G | [FDA Established Pharmacologic Classes] |
Human Immunoglobulin | [FDA Established Pharmacologic Classes] |
Human Platelet-derived Growth Factor | [FDA Established Pharmacologic Classes] |
Human Serum Albumin | [FDA Established Pharmacologic Classes] |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme | [FDA Established Pharmacologic Classes] |
Hydrolytic Lysosomal Glycogen-specific Enzyme | [FDA Established Pharmacologic Classes] |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme | [FDA Established Pharmacologic Classes] |
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme | [FDA Established Pharmacologic Classes] |
Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor | [FDA Established Pharmacologic Classes] |
Immunoglobulin G | [FDA Established Pharmacologic Classes] |
Inactivated Salmonella Typhi Vaccine | [FDA Established Pharmacologic Classes] |
Influenza A M2 Protein Inhibitor | [FDA Established Pharmacologic Classes] |
Inhalation Diagnostic Agent | [FDA Established Pharmacologic Classes] |
Insulin Analog | [FDA Established Pharmacologic Classes] |
Insulin | [FDA Established Pharmacologic Classes] |
Integrin Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Interferon alpha | [FDA Established Pharmacologic Classes] |
Interferon gamma | [FDA Established Pharmacologic Classes] |
Interleukin-1 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Interleukin-2 Receptor Blocking Antibody | [FDA Established Pharmacologic Classes] |
Interleukin-6 Antagonist | [FDA Established Pharmacologic Classes] |
Interleukin-6 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Intestinal Lipase Inhibitor | [FDA Established Pharmacologic Classes] |
Iron Chelator | [FDA Established Pharmacologic Classes] |
Janus Kinase Inhibitor | [FDA Established Pharmacologic Classes] |
Ketolide Antibacterial | [FDA Established Pharmacologic Classes] |
Kinase Inhibitor | [FDA Established Pharmacologic Classes] |
l-Thyroxine | [FDA Established Pharmacologic Classes] |
l-Triiodothyronine | [FDA Established Pharmacologic Classes] |
Lead Chelator | [FDA Established Pharmacologic Classes] |
Leptin Analog | [FDA Established Pharmacologic Classes] |
Leukocyte Growth Factor | [FDA Established Pharmacologic Classes] |
Leukotriene Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Lincosamide Antibacterial | [FDA Established Pharmacologic Classes] |
Lipid Emulsion | [FDA Established Pharmacologic Classes] |
Lipid-based Polyene Antifungal | [FDA Established Pharmacologic Classes] |
Lipoglycopeptide Antibacterial | [FDA Established Pharmacologic Classes] |
Lipopeptide Antibacterial | [FDA Established Pharmacologic Classes] |
Live Attenuated Bacillus Calmette-Guerin Immunotherapy | [FDA Established Pharmacologic Classes] |
Live Attenuated Bacillus Calmette-Guerin Vaccine | [FDA Established Pharmacologic Classes] |
Live Attenuated Mumps Virus Vaccine | [FDA Established Pharmacologic Classes] |
Live Human Adenovirus Type 4 Vaccine | [FDA Established Pharmacologic Classes] |
Live Human Adenovirus Type 7 Vaccine | [FDA Established Pharmacologic Classes] |
Live Rotavirus Vaccine | [FDA Established Pharmacologic Classes] |
Local Anesthetic | [FDA Established Pharmacologic Classes] |
Loop Diuretic | [FDA Established Pharmacologic Classes] |
Low Molecular Weight Heparin | [FDA Established Pharmacologic Classes] |
Lymphocyte Growth Factor | [FDA Established Pharmacologic Classes] |
Macrolide Antibacterial | [FDA Established Pharmacologic Classes] |
Macrolide Antimicrobial | [FDA Established Pharmacologic Classes] |
Macrolide | [FDA Established Pharmacologic Classes] |
Mast Cell Stabilizer | [FDA Established Pharmacologic Classes] |
Megakaryocyte Growth Factor | [FDA Established Pharmacologic Classes] |
Melanin Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
Melatonin Receptor Agonist | [FDA Established Pharmacologic Classes] |
Metal Chelator | [FDA Established Pharmacologic Classes] |
Methylated Sulfonamide Antibacterial | [FDA Established Pharmacologic Classes] |
Methylating Agent | [FDA Established Pharmacologic Classes] |
Methylxanthine | [FDA Established Pharmacologic Classes] |
Microsomal Triglyceride Transfer Protein Inhibitor | [FDA Established Pharmacologic Classes] |
Microtubule Inhibitor | [FDA Established Pharmacologic Classes] |
Monoamine Oxidase Inhibitor | [FDA Established Pharmacologic Classes] |
Monoamine Oxidase Type B Inhibitor | [FDA Established Pharmacologic Classes] |
Monobactam Antibacterial | [FDA Established Pharmacologic Classes] |
Mood Stabilizer | [FDA Established Pharmacologic Classes] |
mTOR Inhibitor Immunosuppressant | [FDA Established Pharmacologic Classes] |
Mucocutaneous Epithelial Cell Growth Factor | [FDA Established Pharmacologic Classes] |
Mucolytic | [FDA Established Pharmacologic Classes] |
Muscle Relaxant | [FDA Established Pharmacologic Classes] |
N-methyl-D-aspartate Receptor Antagonist | [FDA Established Pharmacologic Classes] |
N-type Calcium Channel Antagonist | [FDA Established Pharmacologic Classes] |
Natriuretic Peptide | [FDA Established Pharmacologic Classes] |
Neuraminidase Inhibitor | [FDA Established Pharmacologic Classes] |
Nicotinic Acid | [FDA Established Pharmacologic Classes] |
Nitrate Vasodilator | [FDA Established Pharmacologic Classes] |
Nitrofuran Antibacterial | [FDA Established Pharmacologic Classes] |
Nitrogen Binding Agent | [FDA Established Pharmacologic Classes] |
Nitroimidazole Antimicrobial | [FDA Established Pharmacologic Classes] |
Non-narcotic Antitussive | [FDA Established Pharmacologic Classes] |
Non-Standardized Animal Dander Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Animal Hair Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Animal Skin Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Bacterial Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Chemical Allergen | [FDA Established Pharmacologic Classes] |
Non-Standardized Feather Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Food Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Fungal Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized House Dust Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Insect Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Insect Venom Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Plant Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Plant Fiber Allergenic Extract | [FDA Established Pharmacologic Classes] |
Non-Standardized Pollen Allergenic Extract | [FDA Established Pharmacologic Classes] |
Noncompetitive AMPA Glutamate Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Nondepolarizing Neuromuscular Blocker | [FDA Established Pharmacologic Classes] |
Nonergot Dopamine Agonist | [FDA Established Pharmacologic Classes] |
Nonsteroidal Anti-inflammatory Drug | [FDA Established Pharmacologic Classes] |
Norepinephrine Reuptake Inhibitor | [FDA Established Pharmacologic Classes] |
Nucleoside Analog Antifungal | [FDA Established Pharmacologic Classes] |
Nucleoside Analog Antiviral | [FDA Established Pharmacologic Classes] |
Nucleoside Metabolic Inhibitor | [FDA Established Pharmacologic Classes] |
Omega-3 Fatty Acid | [FDA Established Pharmacologic Classes] |
Opioid Agonist | [FDA Established Pharmacologic Classes] |
Opioid Agonist/Antagonist | [FDA Established Pharmacologic Classes] |
Opioid Antagonist | [FDA Established Pharmacologic Classes] |
Orexin Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Osmotic Diuretic | [FDA Established Pharmacologic Classes] |
Osmotic Laxative | [FDA Established Pharmacologic Classes] |
Oxaborole Antifungal | [FDA Established Pharmacologic Classes] |
Oxazolidinone Antibacterial | [FDA Established Pharmacologic Classes] |
Oxytocic | [FDA Established Pharmacologic Classes] |
P2Y12 Platelet Inhibitor | [FDA Established Pharmacologic Classes] |
Paramagnetic Contrast Agent | [FDA Established Pharmacologic Classes] |
Parathyroid Hormone Analog | [FDA Established Pharmacologic Classes] |
Parathyroid Hormone | [FDA Established Pharmacologic Classes] |
Parenteral Iron Replacement | [FDA Established Pharmacologic Classes] |
Partial Cholinergic Nicotinic Agonist | [FDA Established Pharmacologic Classes] |
Partial Opioid Agonist | [FDA Established Pharmacologic Classes] |
Partial Opioid Agonist/Antagonist | [FDA Established Pharmacologic Classes] |
Pediculicide | [FDA Established Pharmacologic Classes] |
Penem Antibacterial | [FDA Established Pharmacologic Classes] |
Penicillin-class Antibacterial | [FDA Established Pharmacologic Classes] |
Peroxisome Proliferator Receptor alpha Agonist | [FDA Established Pharmacologic Classes] |
Peroxisome Proliferator Receptor gamma Agonist | [FDA Established Pharmacologic Classes] |
Phenothiazine | [FDA Established Pharmacologic Classes] |
Phenylalanine Hydroxylase Activator | [FDA Established Pharmacologic Classes] |
Phosphate Binder | [FDA Established Pharmacologic Classes] |
Phosphodiesterase 3 Inhibitor | [FDA Established Pharmacologic Classes] |
Phosphodiesterase 4 Inhibitor | [FDA Established Pharmacologic Classes] |
Phosphodiesterase 5 Inhibitor | [FDA Established Pharmacologic Classes] |
Photoactivated Radical Generator | [FDA Established Pharmacologic Classes] |
Photoenhancer | [FDA Established Pharmacologic Classes] |
Plasma Volume Expander | [FDA Established Pharmacologic Classes] |
Platelet Aggregation Inhibitor | [FDA Established Pharmacologic Classes] |
Platelet-reducing Agent | [FDA Established Pharmacologic Classes] |
Platinum-based Drug | [FDA Established Pharmacologic Classes] |
Pleuromutilin Antibacterial | [FDA Established Pharmacologic Classes] |
Polyene Antifungal | [FDA Established Pharmacologic Classes] |
Polyene Antimicrobial | [FDA Established Pharmacologic Classes] |
Polymyxin-class Antibacterial | [FDA Established Pharmacologic Classes] |
Porphyrin Precursor | [FDA Established Pharmacologic Classes] |
Potassium Channel Opener | [FDA Established Pharmacologic Classes] |
Potassium Salt | [FDA Established Pharmacologic Classes] |
Potassium-sparing Diuretic | [FDA Established Pharmacologic Classes] |
Progesterone Agonist/Antagonist | [FDA Established Pharmacologic Classes] |
Progesterone | [FDA Established Pharmacologic Classes] |
Progestin Antagonist | [FDA Established Pharmacologic Classes] |
Progestin | [FDA Established Pharmacologic Classes] |
Progestin-containing Intrauterine Device | [FDA Established Pharmacologic Classes] |
Programmed Death Receptor-1 Blocking Antibody | [FDA Established Pharmacologic Classes] |
Prostacycline Vasodilator | [FDA Established Pharmacologic Classes] |
Prostacycline | [FDA Established Pharmacologic Classes] |
Prostaglandin Analog | [FDA Established Pharmacologic Classes] |
Prostaglandin E1 Agonist | [FDA Established Pharmacologic Classes] |
Prostaglandin E1 Analog | [FDA Established Pharmacologic Classes] |
Protease Inhibitor | [FDA Established Pharmacologic Classes] |
Protease-activated Receptor-1 Antagonist | [FDA Established Pharmacologic Classes] |
Proteasome Inhibitor | [FDA Established Pharmacologic Classes] |
Proton Pump Inhibitor | [FDA Established Pharmacologic Classes] |
Provitamin D2 Compound | [FDA Established Pharmacologic Classes] |
Psoralen | [FDA Established Pharmacologic Classes] |
Purine Antimetabolite | [FDA Established Pharmacologic Classes] |
Pyrethroid | [FDA Established Pharmacologic Classes] |
Pyridone | [FDA Established Pharmacologic Classes] |
Pyrimidine Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
Pyrophosphate Analog DNA Polymerase Inhibitor | [FDA Established Pharmacologic Classes] |
Quinolone Antimicrobial | [FDA Established Pharmacologic Classes] |
Radioactive Diagnostic Agent | [FDA Established Pharmacologic Classes] |
Radioactive Therapeutic Agent | [FDA Established Pharmacologic Classes] |
Radiographic Contrast Agent | [FDA Established Pharmacologic Classes] |
RANK Ligand Inhibitor | [FDA Established Pharmacologic Classes] |
Recombinant Antithrombin | [FDA Established Pharmacologic Classes] |
Recombinant Human Deoxyribonuclease 1 | [FDA Established Pharmacologic Classes] |
Recombinant Human Growth Hormone | [FDA Established Pharmacologic Classes] |
Recombinant Human Interferon beta | [FDA Established Pharmacologic Classes] |
Reducing and Complexing Thiol | [FDA Established Pharmacologic Classes] |
Renal Dehydropeptidase Inhibitor | [FDA Established Pharmacologic Classes] |
Renin Inhibitor | [FDA Established Pharmacologic Classes] |
Respiratory Stimulant | [FDA Established Pharmacologic Classes] |
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody | [FDA Established Pharmacologic Classes] |
Retinoid | [FDA Established Pharmacologic Classes] |
Rifamycin Antibacterial | [FDA Established Pharmacologic Classes] |
Rifamycin Antimycobacterial | [FDA Established Pharmacologic Classes] |
RNA Synthetase Inhibitor Antibacterial | [FDA Established Pharmacologic Classes] |
Sclerosing Agent | [FDA Established Pharmacologic Classes] |
Selective T Cell Costimulation Blocker | [FDA Established Pharmacologic Classes] |
Selective T Cell Costimulation Modulator | [FDA Established Pharmacologic Classes] |
Serotonin and Norepinephrine Reuptake Inhibitor | [FDA Established Pharmacologic Classes] |
Serotonin Reuptake Inhibitor | [FDA Established Pharmacologic Classes] |
Serotonin-1b and Serotonin-1d Receptor Agonist | [FDA Established Pharmacologic Classes] |
Serotonin-2c Receptor Agonist | [FDA Established Pharmacologic Classes] |
Serotonin-3 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Serotonin-4 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Sigma-1 Agonist | [FDA Established Pharmacologic Classes] |
Skeletal Muscle Relaxant | [FDA Established Pharmacologic Classes] |
Skin Test Antigen | [FDA Established Pharmacologic Classes] |
Sodium-Glucose Cotransporter 2 Inhibitor | [FDA Established Pharmacologic Classes] |
Soluble Guanylate Cyclase Stimulator | [FDA Established Pharmacologic Classes] |
Somatostatin Analog | [FDA Established Pharmacologic Classes] |
Sphingosine 1-phosphate Receptor Modulator | [FDA Established Pharmacologic Classes] |
Standardized Animal Hair Allergenic Extract | [FDA Established Pharmacologic Classes] |
Standardized Animal Skin Allergenic Extract | [FDA Established Pharmacologic Classes] |
Standardized Chemical Allergen | [FDA Established Pharmacologic Classes] |
Standardized Insect Allergenic Extract | [FDA Established Pharmacologic Classes] |
Standardized Insect Venom Allergenic Extract | [FDA Established Pharmacologic Classes] |
Standardized Pollen Allergenic Extract | [FDA Established Pharmacologic Classes] |
Stimulant Laxative | [FDA Established Pharmacologic Classes] |
Streptogramin Antibacterial | [FDA Established Pharmacologic Classes] |
Substance P/Neurokinin-1 Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Sucrose-specific Enzyme | [FDA Established Pharmacologic Classes] |
Sulfonamide Antibacterial | [FDA Established Pharmacologic Classes] |
Sulfonamide Antimicrobial | [FDA Established Pharmacologic Classes] |
Sulfone | [FDA Established Pharmacologic Classes] |
Sulfonylurea | [FDA Established Pharmacologic Classes] |
Surfactant | [FDA Established Pharmacologic Classes] |
Sympathomimetic Amine Anorectic | [FDA Established Pharmacologic Classes] |
Sympathomimetic-like Agent | [FDA Established Pharmacologic Classes] |
Tetracycline-class Antibacterial | [FDA Established Pharmacologic Classes] |
Tetracycline-class Antimicrobial | [FDA Established Pharmacologic Classes] |
Tetracycline-class Drug | [FDA Established Pharmacologic Classes] |
Thalidomide Analog | [FDA Established Pharmacologic Classes] |
Thiazide Diuretic | [FDA Established Pharmacologic Classes] |
Thiazide-like Diuretic | [FDA Established Pharmacologic Classes] |
Thiazolidinedione | [FDA Established Pharmacologic Classes] |
Thrombolytic Agent | [FDA Established Pharmacologic Classes] |
Thrombopoietin Receptor Agonist | [FDA Established Pharmacologic Classes] |
Thyroid Hormone Synthesis Inhibitor | [FDA Established Pharmacologic Classes] |
Thyroid Stimulating Hormone | [FDA Established Pharmacologic Classes] |
Topoisomerase Inhibitor | [FDA Established Pharmacologic Classes] |
Tricyclic Antidepressant | [FDA Established Pharmacologic Classes] |
Tuberculosis Skin Test | [FDA Established Pharmacologic Classes] |
Tumor Necrosis Factor Blocker | [FDA Established Pharmacologic Classes] |
Typical Antipsychotic | [FDA Established Pharmacologic Classes] |
Uncompetitive N-methyl-D-aspartate Receptor Antagonist | [FDA Established Pharmacologic Classes] |
Unfractionated Heparin | [FDA Established Pharmacologic Classes] |
Urease Inhibitor | [FDA Established Pharmacologic Classes] |
Uric Acid-specific Enzyme | [FDA Established Pharmacologic Classes] |
Vascular Endothelial Growth Factor Receptor 2 Antagonist | [FDA Established Pharmacologic Classes] |
Vascular Endothelial Growth Factor-directed Antibody | [FDA Established Pharmacologic Classes] |
Vasodilator | [FDA Established Pharmacologic Classes] |
Vasopressin Analog | [FDA Established Pharmacologic Classes] |
Vasopressin Antagonist | [FDA Established Pharmacologic Classes] |
Vesicular Monoamine Transporter 2 Inhibitor | [FDA Established Pharmacologic Classes] |
Vinca Alkaloid | [FDA Established Pharmacologic Classes] |
Vitamin A | [FDA Established Pharmacologic Classes] |
Vitamin B Complex Member | [FDA Established Pharmacologic Classes] |
Vitamin B12 | [FDA Established Pharmacologic Classes] |
Vitamin D Analog | [FDA Established Pharmacologic Classes] |
Vitamin D | [FDA Established Pharmacologic Classes] |
Vitamin D2 Analog | [FDA Established Pharmacologic Classes] |
Vitamin D3 Analog | [FDA Established Pharmacologic Classes] |
Vitamin K Antagonist | [FDA Established Pharmacologic Classes] |
Vitamin K | [FDA Established Pharmacologic Classes] |
Warfarin Reversal Agent | [FDA Established Pharmacologic Classes] |
Xanthine Oxidase Inhibitor | [FDA Established Pharmacologic Classes] |
5-alpha Reductase Inhibitors | [Mechanism of Action] |
5-Lipoxygenase Inhibitors | [Mechanism of Action] |
Acetyl Aldehyde Dehydrogenase Inhibitors | [Mechanism of Action] |
Acetylcholine Release Inhibitors | [Mechanism of Action] |
Acidifying Activity | [Mechanism of Action] |
Adenosine Receptor Agonists | [Mechanism of Action] |
Adrenal Steroid Synthesis Inhibitors | [Mechanism of Action] |
Adrenergic Agonists | [Mechanism of Action] |
Adrenergic alpha-Agonists | [Mechanism of Action] |
Adrenergic alpha-Antagonists | [Mechanism of Action] |
Adrenergic alpha1-Agonists | [Mechanism of Action] |
Adrenergic alpha2-Agonists | [Mechanism of Action] |
Adrenergic beta-Agonists | [Mechanism of Action] |
Adrenergic beta-Antagonists | [Mechanism of Action] |
Adrenergic beta1-Antagonists | [Mechanism of Action] |
Adrenergic beta2-Agonists | [Mechanism of Action] |
Adrenergic beta2-Antagonists | [Mechanism of Action] |
Adrenergic beta3-Agonists | [Mechanism of Action] |
Aldosterone Antagonists | [Mechanism of Action] |
Alkylating Activity | [Mechanism of Action] |
alpha Glucosidase Inhibitors | [Mechanism of Action] |
Ammonium Ion Binding Activity | [Mechanism of Action] |
AMPA Receptor Antagonists | [Mechanism of Action] |
Amylin Agonists | [Mechanism of Action] |
Androgen Receptor Agonists | [Mechanism of Action] |
Androgen Receptor Antagonists | [Mechanism of Action] |
Angiotensin 2 Receptor Antagonists | [Mechanism of Action] |
Angiotensin 2 Type 1 Receptor Antagonists | [Mechanism of Action] |
Angiotensin-converting Enzyme Inhibitors | [Mechanism of Action] |
Antibody-Surface Protein Interactions | [Mechanism of Action] |
Antidiuretic Hormone Antagonists | [Mechanism of Action] |
Antigen Neutralization | [Mechanism of Action] |
Aromatase Inhibitors | [Mechanism of Action] |
B Lymphocyte Stimulator-directed Antibody Interactions | [Mechanism of Action] |
Bacterial Neurotoxin Neutralization | [Mechanism of Action] |
beta Lactamase Inhibitors | [Mechanism of Action] |
Bile-acid Binding Activity | [Mechanism of Action] |
Bradykinin B2 Receptor Antagonists | [Mechanism of Action] |
Breast Cancer Resistance Protein Inhibitors | [Mechanism of Action] |
Calcineurin Inhibitors | [Mechanism of Action] |
Calcium Channel Antagonists | [Mechanism of Action] |
Calcium Chelating Activity | [Mechanism of Action] |
Carbamoyl Phosphate Synthetase 1 Activators | [Mechanism of Action] |
Carbonic Anhydrase Inhibitors | [Mechanism of Action] |
Catechol O-Methyltransferase Inhibitors | [Mechanism of Action] |
Catecholamine Synthesis Inhibitors | [Mechanism of Action] |
CD20-directed Antibody Interactions | [Mechanism of Action] |
CD3 Receptor Antagonists | [Mechanism of Action] |
CD3-directed Antibody Interactions | [Mechanism of Action] |
CD30-directed Antibody Interactions | [Mechanism of Action] |
CD52-directed Antibody Interactions | [Mechanism of Action] |
CD80-directed Antibody Interactions | [Mechanism of Action] |
CD86-directed Antibody Interactions | [Mechanism of Action] |
Chemokine Co-receptor 5 Antagonists | [Mechanism of Action] |
Chloride Channel Activation Potentiators | [Mechanism of Action] |
Chloride Channel Activators | [Mechanism of Action] |
Cholinergic Agonists | [Mechanism of Action] |
Cholinergic Antagonists | [Mechanism of Action] |
Cholinergic Muscarinic Agonists | [Mechanism of Action] |
Cholinergic Muscarinic Antagonists | [Mechanism of Action] |
Cholinesterase Inhibitors | [Mechanism of Action] |
Cholinesterase Reactivators | [Mechanism of Action] |
Competitive Opioid Antagonists | [Mechanism of Action] |
Complement Inhibitors | [Mechanism of Action] |
Corticosteroid Hormone Receptor Agonists | [Mechanism of Action] |
CTLA-4-directed Antibody Interactions | [Mechanism of Action] |
Cyclooxygenase Inhibitors | [Mechanism of Action] |
Cystine Disulfide Reduction | [Mechanism of Action] |
Cytochrome P450 17A1 Inhibitors | [Mechanism of Action] |
Cytochrome P450 1A2 Inducers | [Mechanism of Action] |
Cytochrome P450 1A2 Inhibitors | [Mechanism of Action] |
Cytochrome P450 2B6 Inducers | [Mechanism of Action] |
Cytochrome P450 2B6 Inhibitors | [Mechanism of Action] |
Cytochrome P450 2C19 Inducers | [Mechanism of Action] |
Cytochrome P450 2C19 Inhibitors | [Mechanism of Action] |
Cytochrome P450 2C8 Inducers | [Mechanism of Action] |
Cytochrome P450 2C8 Inhibitors | [Mechanism of Action] |
Cytochrome P450 2C9 Inducers | [Mechanism of Action] |
Cytochrome P450 2C9 Inhibitors | [Mechanism of Action] |
Cytochrome P450 2D6 Inducers | [Mechanism of Action] |
Cytochrome P450 2D6 Inhibitors | [Mechanism of Action] |
Cytochrome P450 3A Inducers | [Mechanism of Action] |
Cytochrome P450 3A Inhibitors | [Mechanism of Action] |
Cytochrome P450 3A4 Inducers | [Mechanism of Action] |
Cytochrome P450 3A4 Inhibitors | [Mechanism of Action] |
Cytochrome P450 3A5 Inhibitors | [Mechanism of Action] |
Decarboxylase Inhibitors | [Mechanism of Action] |
Demulcent Activity | [Mechanism of Action] |
Digoxin Binding Activity | [Mechanism of Action] |
Dihydrofolate Reductase Inhibitors | [Mechanism of Action] |
Dihydroorotate Dehydrogenase Inhibitors | [Mechanism of Action] |
Dipeptidase Inhibitors | [Mechanism of Action] |
Dipeptidyl Peptidase 4 Inhibitors | [Mechanism of Action] |
DNA Polymerase Inhibitors | [Mechanism of Action] |
DOPA Decarboxylase Inhibitors | [Mechanism of Action] |
Dopamine Agonists | [Mechanism of Action] |
Dopamine D2 Antagonists | [Mechanism of Action] |
Dopamine Uptake Inhibitors | [Mechanism of Action] |
Dyes | [Mechanism of Action] |
Endogenous Antigen Neutralization | [Mechanism of Action] |
Endothelin Receptor Antagonists | [Mechanism of Action] |
Estrogen Receptor Agonists | [Mechanism of Action] |
Estrogen Receptor Antagonists | [Mechanism of Action] |
Factor Xa Inhibitors | [Mechanism of Action] |
Folic Acid Metabolism Inhibitors | [Mechanism of Action] |
Free Radical Scavenging Activity | [Mechanism of Action] |
Full Opioid Agonists | [Mechanism of Action] |
Fusion Protein Inhibitors | [Mechanism of Action] |
GABA A Agonists | [Mechanism of Action] |
GABA B Agonists | [Mechanism of Action] |
Glucagon-like Peptide-1 (GLP-1) Agonists | [Mechanism of Action] |
Glucosylceramide Synthase Inhibitors | [Mechanism of Action] |
Gonadotropin Releasing Hormone Receptor Agonists | [Mechanism of Action] |
Gonadotropin Releasing Hormone Receptor Antagonists | [Mechanism of Action] |
Growth Hormone Receptor Antagonists | [Mechanism of Action] |
Guanylate Cyclase Activators | [Mechanism of Action] |
Guanylate Cyclase Stimulators | [Mechanism of Action] |
HCV NS3/4A Protease Inhibitors | [Mechanism of Action] |
Heparin Binding Activity | [Mechanism of Action] |
HER1 Antagonists | [Mechanism of Action] |
HER2/Neu/cerbB2 Antagonists | [Mechanism of Action] |
Histamine H1 Receptor Antagonists | [Mechanism of Action] |
Histamine H2 Receptor Antagonists | [Mechanism of Action] |
Histamine Receptor Antagonists | [Mechanism of Action] |
Histone Deacetylase Inhibitors | [Mechanism of Action] |
HIV Integrase Inhibitors | [Mechanism of Action] |
HIV Protease Inhibitors | [Mechanism of Action] |
Hydroxymethylglutaryl-CoA Reductase Inhibitors | [Mechanism of Action] |
Hydroxyphenylpyruvate Dioxygenase Inhibitors | [Mechanism of Action] |
IgE-directed Antibody Interactions | [Mechanism of Action] |
Increased Calcium-sensing Receptor Sensitivity | [Mechanism of Action] |
Integrin Receptor Antagonists | [Mechanism of Action] |
Interferon Inducers | [Mechanism of Action] |
Interleukin 1 Receptor Antagonists | [Mechanism of Action] |
Interleukin 2 Receptor Antagonists | [Mechanism of Action] |
Interleukin 2 Receptor-directed Antibody Interactions | [Mechanism of Action] |
Interleukin 6 Receptor Antagonists | [Mechanism of Action] |
Interleukin-6 Antagonists | [Mechanism of Action] |
Iron Chelating Activity | [Mechanism of Action] |
Irrigation | [Mechanism of Action] |
Janus Kinase Inhibitors | [Mechanism of Action] |
Kallikrein Inhibitors | [Mechanism of Action] |
Kinase Inhibitors | [Mechanism of Action] |
Lead Chelating Activity | [Mechanism of Action] |
Leukotriene Receptor Antagonists | [Mechanism of Action] |
Lipase Inhibitors | [Mechanism of Action] |
M2 Protein Inhibitors | [Mechanism of Action] |
Magnesium Ion Exchange Activity | [Mechanism of Action] |
Magnetic Resonance Contrast Activity | [Mechanism of Action] |
Melanin Synthesis Inhibitors | [Mechanism of Action] |
Melatonin Receptor Agonists | [Mechanism of Action] |
Metal Chelating Activity | [Mechanism of Action] |
Methylating Activity | [Mechanism of Action] |
Microsomal Triglyceride Transfer Protein Inhibitors | [Mechanism of Action] |
Monoamine Oxidase Inhibitors | [Mechanism of Action] |
Monoamine Oxidase-B Inhibitors | [Mechanism of Action] |
mTOR Inhibitors | [Mechanism of Action] |
Multidrug and Toxin Extrusion Transporter 1 Inhibitors | [Mechanism of Action] |
N-Calcium Channel Receptor Antagonists | [Mechanism of Action] |
Neuraminidase Inhibitors | [Mechanism of Action] |
Neurokinin 1 Antagonists | [Mechanism of Action] |
NMDA Receptor Antagonists | [Mechanism of Action] |
Non-Nucleoside Reverse Transcriptase Inhibitors | [Mechanism of Action] |
Norepinephrine Uptake Inhibitors | [Mechanism of Action] |
Nucleic Acid Synthesis Inhibitors | [Mechanism of Action] |
Nucleoside Reverse Transcriptase Inhibitors | [Mechanism of Action] |
Opioid Agonists | [Mechanism of Action] |
Opioid Antagonists | [Mechanism of Action] |
Orexin Receptor Antagonists | [Mechanism of Action] |
Organic Anion Transporter 1 Inhibitors | [Mechanism of Action] |
Organic Anion Transporter 3 Inhibitors | [Mechanism of Action] |
Organic Anion Transporting Polypeptide 1B1 Inhibitors | [Mechanism of Action] |
Organic Anion Transporting Polypeptide 1B3 Inhibitors | [Mechanism of Action] |
Organic Cation Transporter 1 Inhibitors | [Mechanism of Action] |
Organic Cation Transporter 2 Inhibitors | [Mechanism of Action] |
Osmotic Activity | [Mechanism of Action] |
P-Glycoprotein Inhibitors | [Mechanism of Action] |
P-Glycoprotein Interactions | [Mechanism of Action] |
P2Y12 Receptor Antagonists | [Mechanism of Action] |
Partial Cholinergic Nicotinic Agonists | [Mechanism of Action] |
Partial Opioid Agonists | [Mechanism of Action] |
Peroxisome Proliferator-activated Receptor Activity | [Mechanism of Action] |
Peroxisome Proliferator-activated Receptor alpha Agonists | [Mechanism of Action] |
Phenylalanine Hydroxylase Activators | [Mechanism of Action] |
Phosphate Chelating Activity | [Mechanism of Action] |
Phosphodiesterase 3 Inhibitors | [Mechanism of Action] |
Phosphodiesterase 4 Inhibitors | [Mechanism of Action] |
Phosphodiesterase 5 Inhibitors | [Mechanism of Action] |
Photoabsorption | [Mechanism of Action] |
Positron Emitting Activity | [Mechanism of Action] |
Potassium Channel Antagonists | [Mechanism of Action] |
Potassium Channel Openers | [Mechanism of Action] |
Progestational Hormone Receptor Antagonists | [Mechanism of Action] |
Programmed Death Receptor-1-directed Antibody Interactions | [Mechanism of Action] |
Prostaglandin Receptor Agonists | [Mechanism of Action] |
Protease-activated Receptor-1 Antagonists | [Mechanism of Action] |
Proteasome Inhibitors | [Mechanism of Action] |
Protein Kinase Inhibitors | [Mechanism of Action] |
Protein Synthesis Inhibitors | [Mechanism of Action] |
Proton Pump Inhibitors | [Mechanism of Action] |
Radiopharmaceutical Activity | [Mechanism of Action] |
RANK Ligand Blocking Activity | [Mechanism of Action] |
Receptor Tyrosine Kinase Inhibitors | [Mechanism of Action] |
Reduction Activity | [Mechanism of Action] |
Renin Inhibitors | [Mechanism of Action] |
RNA Replicase Inhibitors | [Mechanism of Action] |
RNA Synthetase Inhibitors | [Mechanism of Action] |
Sclerosing Activity | [Mechanism of Action] |
Selective Estrogen Receptor Modulators | [Mechanism of Action] |
Selective Progesterone Receptor Modulators | [Mechanism of Action] |
Serotonin 1b Receptor Agonists | [Mechanism of Action] |
Serotonin 1d Receptor Agonists | [Mechanism of Action] |
Serotonin 2c Receptor Agonists | [Mechanism of Action] |
Serotonin 3 Receptor Antagonists | [Mechanism of Action] |
Serotonin 4 Receptor Antagonists | [Mechanism of Action] |
Serotonin Uptake Inhibitors | [Mechanism of Action] |
Sigma-1 Receptor Agonists | [Mechanism of Action] |
Smoothened Receptor Antagonists | [Mechanism of Action] |
Sodium-Glucose Transporter 2 Inhibitors | [Mechanism of Action] |
Somatostatin Receptor Agonists | [Mechanism of Action] |
Sphingosine 1-Phosphate Receptor Modulators | [Mechanism of Action] |
Surfactant Activity | [Mechanism of Action] |
Thrombin Inhibitors | [Mechanism of Action] |
Thrombopoietin Receptor Agonists | [Mechanism of Action] |
Thyroid Hormone Synthesis Inhibitors | [Mechanism of Action] |
Topoisomerase Inhibitors | [Mechanism of Action] |
Trypsin Inhibitors | [Mechanism of Action] |
Tumor Necrosis Factor alpha Receptor Blocking Activity | [Mechanism of Action] |
Tumor Necrosis Factor Receptor Blocking Activity | [Mechanism of Action] |
UGT1A1 Inhibitors | [Mechanism of Action] |
UGT1A3 Inhibitors | [Mechanism of Action] |
UGT1A4 Inhibitors | [Mechanism of Action] |
UGT1A6 Inhibitors | [Mechanism of Action] |
UGT1A9 Inhibitors | [Mechanism of Action] |
UGT2B15 Inhibitors | [Mechanism of Action] |
UGT2B7 Inhibitors | [Mechanism of Action] |
Ultrasound Contrast Activity | [Mechanism of Action] |
Uncompetitive NMDA Receptor Antagonists | [Mechanism of Action] |
Urease Inhibitors | [Mechanism of Action] |
Vascular Endothelial Growth Factor Receptor Inhibitors | [Mechanism of Action] |
Vascular Endothelial Growth Factor-directed Antibody Interactions | [Mechanism of Action] |
VEGFR2 Inhibitors | [Mechanism of Action] |
Venom Neutralization | [Mechanism of Action] |
Vesicular Monoamine Transporter 2 Inhibitors | [Mechanism of Action] |
Virus Neutralization | [Mechanism of Action] |
Vitamin K Inhibitors | [Mechanism of Action] |
X-Ray Contrast Activity | [Mechanism of Action] |
Xanthine Oxidase Inhibitors | [Mechanism of Action] |
Actively Acquired Immunity | [Physiologic Effect] |
Alveolar Surface Tension Reduction | [Physiologic Effect] |
Appetite Suppression | [Physiologic Effect] |
Arteriolar Vasodilation | [Physiologic Effect] |
Cardiac Rhythm Alteration | [Physiologic Effect] |
Cell-mediated Immunity | [Physiologic Effect] |
Central Nervous System Depression | [Physiologic Effect] |
Central Nervous System Stimulation | [Physiologic Effect] |
Centrally-mediated Muscle Relaxation | [Physiologic Effect] |
Decreased Autonomic Ganglionic Activity | [Physiologic Effect] |
Decreased B Lymphocyte Activation | [Physiologic Effect] |
Decreased Blood Pressure | [Physiologic Effect] |
Decreased Cell Wall Integrity | [Physiologic Effect] |
Decreased Cell Wall Synthesis & Repair | [Physiologic Effect] |
Decreased Central Nervous System Disorganized Electrical Activity | [Physiologic Effect] |
Decreased Central Nervous System Organized Electrical Activity | [Physiologic Effect] |
Decreased Cholesterol Absorption | [Physiologic Effect] |
Decreased Coagulation Factor Activity | [Physiologic Effect] |
Decreased Copper Ion Absorption | [Physiologic Effect] |
Decreased Cytokine Activity | [Physiologic Effect] |
Decreased DNA Replication | [Physiologic Effect] |
Decreased Embryonic Implantation | [Physiologic Effect] |
Decreased Fibrinolysis | [Physiologic Effect] |
Decreased GI Motility | [Physiologic Effect] |
Decreased GI Smooth Muscle Tone | [Physiologic Effect] |
Decreased Glycolysis | [Physiologic Effect] |
Decreased GnRH Secretion | [Physiologic Effect] |
Decreased Histamine Release | [Physiologic Effect] |
Decreased IgE Activity | [Physiologic Effect] |
Decreased Immunologic Activity | [Physiologic Effect] |
Decreased Immunologically Active Molecule Activity | [Physiologic Effect] |
Decreased Leukotriene Production | [Physiologic Effect] |
Decreased Mitosis | [Physiologic Effect] |
Decreased Parasympathetic Acetylcholine Activity | [Physiologic Effect] |
Decreased Platelet Aggregation | [Physiologic Effect] |
Decreased Platelet Production | [Physiologic Effect] |
Decreased Prostaglandin Production | [Physiologic Effect] |
Decreased Protein Synthesis | [Physiologic Effect] |
Decreased Renal K+ Excretion | [Physiologic Effect] |
Decreased Respiratory Secretion Viscosity | [Physiologic Effect] |
Decreased RNA Replication | [Physiologic Effect] |
Decreased Sebaceous Gland Activity | [Physiologic Effect] |
Decreased Sperm Motility | [Physiologic Effect] |
Decreased Striated Muscle Contraction | [Physiologic Effect] |
Decreased Striated Muscle Tone | [Physiologic Effect] |
Decreased Sympathetic Activity | [Physiologic Effect] |
Decreased Tracheobronchial Stretch Receptor Activity | [Physiologic Effect] |
Decreased Vascular Permeability | [Physiologic Effect] |
Depigmenting Activity | [Physiologic Effect] |
Digestive/GI System Activity Alteration | [Physiologic Effect] |
Emesis Suppression | [Physiologic Effect] |
General Anesthesia | [Physiologic Effect] |
Genitourinary Arterial Vasodilation | [Physiologic Effect] |
GI Motility Alteration | [Physiologic Effect] |
Hematologic Activity Alteration | [Physiologic Effect] |
Increased Acetylcholine Activity | [Physiologic Effect] |
Increased Blood Pressure | [Physiologic Effect] |
Increased Cellular Death | [Physiologic Effect] |
Increased Coagulation Activity | [Physiologic Effect] |
Increased Coagulation Factor Activity | [Physiologic Effect] |
Increased Coagulation Factor IX Activity | [Physiologic Effect] |
Increased Coagulation Factor VIII Activity | [Physiologic Effect] |
Increased Coagulation Factor VIII Concentration | [Physiologic Effect] |
Increased Coagulation Factor X Activity | [Physiologic Effect] |
Increased Cytokine Activity | [Physiologic Effect] |
Increased Cytokine Production | [Physiologic Effect] |
Increased Diuresis at Loop of Henle | [Physiologic Effect] |
Increased Diuresis | [Physiologic Effect] |
Increased Dopamine Activity | [Physiologic Effect] |
Increased Epithelial Proliferation | [Physiologic Effect] |
Increased Erythroid Cell Production | [Physiologic Effect] |
Increased Fibrin Polymerization Activity | [Physiologic Effect] |
Increased GHRH Activity | [Physiologic Effect] |
Increased Gluconeogenesis | [Physiologic Effect] |
Increased Glutathione Concentration | [Physiologic Effect] |
Increased Glycogenolysis | [Physiologic Effect] |
Increased Hematopoietic Stem Cell Mobilization | [Physiologic Effect] |
Increased Histamine Release | [Physiologic Effect] |
Increased IgG Production | [Physiologic Effect] |
Increased Immunologically Active Molecule Activity | [Physiologic Effect] |
Increased Intravascular Volume | [Physiologic Effect] |
Increased Large Intestinal Motility | [Physiologic Effect] |
Increased Lymphocyte Activation | [Physiologic Effect] |
Increased Lymphocyte Cell Production | [Physiologic Effect] |
Increased Macrophage Proliferation | [Physiologic Effect] |
Increased Medullary Respiratory Drive | [Physiologic Effect] |
Increased Megakaryocyte Maturation | [Physiologic Effect] |
Increased Myeloid Cell Production | [Physiologic Effect] |
Increased Norepinephrine Activity | [Physiologic Effect] |
Increased Oncotic Pressure | [Physiologic Effect] |
Increased Platelet Aggregation | [Physiologic Effect] |
Increased Platelet Production | [Physiologic Effect] |
Increased Prostaglandin Activity | [Physiologic Effect] |
Increased Prothrombin Activity | [Physiologic Effect] |
Increased Sympathetic Activity | [Physiologic Effect] |
Increased T Lymphocyte Activation | [Physiologic Effect] |
Increased T Lymphocyte Destruction | [Physiologic Effect] |
Increased Thrombolysis | [Physiologic Effect] |
Increased Uterine Smooth Muscle Contraction or Tone | [Physiologic Effect] |
Inhibit Ovum Fertilization | [Physiologic Effect] |
Local Anesthesia | [Physiologic Effect] |
Lymphocyte Function Alteration | [Physiologic Effect] |
Microtubule Inhibition | [Physiologic Effect] |
Neuromuscular Depolarizing Blockade | [Physiologic Effect] |
Neuromuscular Nondepolarizing Blockade | [Physiologic Effect] |
Passively Acquired Immunity | [Physiologic Effect] |
Photosensitizing Activity | [Physiologic Effect] |
Reversed Anticoagulation Activity | [Physiologic Effect] |
Skin Barrier Activity | [Physiologic Effect] |
Stimulation Large Intestine Fluid/Electrolyte Secretion | [Physiologic Effect] |
T Lymphocyte Costimulation Activity Blockade | [Physiologic Effect] |
Vascular Sclerosing Activity | [Physiologic Effect] |
Vasodilation | [Physiologic Effect] |
Venous Vasodilation | [Physiologic Effect] |